CHOLESTASIS SYNDROME IN THE CLINIC OF INFECTIOUS DISEASES. (CLINICAL OBSERVATION)
DOI:
https://doi.org/10.34689/50ypr924Keywords:
cholestatsis , viral hepatitis , ademetioninAbstract
In article authors presented clinical observation of the patient with chronic viral hepatitis B with cholestasis, moderate severity. In treatment of the leading syndrome of cholestatsis ademetionin can be used. Clinically proved high efficacy of the
drug as pathogenetic treatment of cholestasis is combined with a high degree of safety that allows us to recommend the drug
for the treatment of intrahepatic cholestasis of various origins to all patients.
References
СИНДРОМ ХОЛЕСТАЗА В КЛИНИКЕ ИНФЕКЦИОННЫХ БОЛЕЗНЕЙ.(КЛИНИЧЕСКОЕ НАБЛЮДЕНИЕ)
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Е.М. Смаил, Сауле Маукаева, Алма Токаева, К.Б. Малгаждарова, Д.Т. Кусаинова, Г.С. Мухамадиева (Автор)

This work is licensed under a Creative Commons Attribution 4.0 International License.